Skip to content

Discontinued — last reported Q1 '26

Net Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Stryker logo
StrykerSYK
$745M+13.9%
PDE
Pro-Dex, Inc.PDEX
$3.94M+20.2%
CONMED logo
CONMEDCNMD
$13.83M+129%
Vericel logo
VericelVCEL
-$6.3M+44.0%
Globus Medical logo
Globus MedicalGMED
$124.3M+64.7%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.61B-6.5%
Enterprise value$24.66B-4.6%
P/E23.1×+0.3×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's net income?
Zimmer Biomet Holdings (ZBH) reported net income of $238.1M in Q1 2026.
How has Zimmer Biomet Holdings's net income changed year-over-year?
Zimmer Biomet Holdings's net income increased by 30.8% year-over-year, from $182M to $238.1M.
What is the long-term trend for Zimmer Biomet Holdings's net income?
Over 2 years (2023 to 2025), Zimmer Biomet Holdings's net income has grown at a -17.0% compound annual growth rate (CAGR), from $1.02B to $705M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.